PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Jul-2024 ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors ImmunOs Therapeutics
24-Jul-2024 SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) SpyBiotech
24-Jul-2024 Alfa Chemistry Extends Product Line with Comprehensive PTFE , PCTFE , ETFE, and Fluoropolymer Coatings Offerings Alfa Chemistry
23-Jul-2024 Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial PureTech Health
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1 ViiV Healthcare
23-Jul-2024 ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024 ViiV Healthcare
23-Jul-2024 ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor AIDS 2024 ViiV Healthcare
23-Jul-2024 Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs Xeltis
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 CD Genomics Debuts Next-Generation Nanopore Sequencing Services for Unlocking Genomic Secrets CD Genomics
23-Jul-2024 CD Genomics Unveils Advanced Whole Genome Sequencing Solutions for Comprehensive Genetic Insights CD Genomics
22-Jul-2024 Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals Avista Capital Partners
22-Jul-2024 Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024 Transgene
22-Jul-2024 Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis Certa Therapeutics
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Research reveals the greatest fear of life sciences tech leaders: cyber espionage NTT DATA
22-Jul-2024 Pioneering biotech extends collaboration with leading global drug researcher to boost search for rare disease therapies SynaptixBio
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Pioneering biotech extends collaboration with leading global drug researcher to boost search for rare disease therapies SynaptixBio